Bunge Limited

Valuation Analysis

About the Company

Bunge Limited en bref

Bunge Limited (BG) is currently trading at 98,13 € with a market capitalization of 19,0 Md €. The trailing P/E ratio stands at 29.62x, with a forward P/E of 10.34x. The 52-week range spans from 62,42 € to 117,57 €; the current price is 16.5% below the yearly high. Year-over-year revenue growth stands at +87.8%. The net profit margin stands at 0.85%.

💰 Dividende

Bunge Limited pays an annual dividend of 2,51 € per share, representing a yield of 2.56%. The payout ratio stands at 73.68%.

📊 Avis des analystes

9 analystes évaluent Bunge Limited (BG) au consensus : Acheter. L'objectif de cours moyen est de 123,79 €, soit un potentiel de +26.15% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 101,12 € à 130,76 €.

Bunge Limited : la thèse d'investissement en détail

Bunge Limited (BG) operates in the Consumer Defensive — specifically Farm Products — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Top-line momentum is unusually strong with revenue expanding 87.8% year-over-year, a pace that puts the company well above the market average and signals genuine demand traction rather than mere cyclical tailwind. Wall Street consensus sits at Buy with an average price target implying roughly 26.15% upside from current levels — analyst sentiment is firmly constructive.

Le scénario baissier

With a net margin of just 0.85%, the business has little room to absorb cost shocks or pricing pressure — a single bad quarter can swing the company to a loss.

Valorisation en contexte

The PEG ratio at 1.37 sits in the reasonable zone — the price tag is roughly aligned with the company's growth profile, neither punishing nor euphoric.

À surveiller

• The forward P/E of 10.34x is meaningfully below the trailing 29.62x — analysts expect earnings to step up; the next earnings release is the test.
• The analyst consensus price target implies 26.15% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price shows short-term weakness (below 50d MA) but is still in a longer-term uptrend (above 200d MA).

Profil de risque

The data points to relatively defensive market behavior.

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Bunge Limited?

Compare top-rated brokers — low fees, trusted providers, fully regulated.